Literature DB >> 18838743

Reaction times and performance variability in normal aging, mild cognitive impairment, and Alzheimer's disease.

Ellen Gorus1, Rudi De Raedt, Margareta Lambert, Jean-Claude Lemper, Tony Mets.   

Abstract

This study evaluated whether reaction times (RT) and performance variability are potential markers for the early detection of Alzheimer's disease (AD). Cognitively healthy elderly (n = 218), persons with amnestic MCI (a-MCI) (n = 29) and patients with AD (n = 50) were examined with RT tasks with increasing complexity, subdividing RT into a decision and a movement component. Persons with cognitive deterioration demonstrated more intra-individual variability and more slowing than cognitively healthy elderly. The slowing in AD affects both the cognitive and the motor component, while performance variability mainly affects the cognitive component of the RT. Although in a-MCI not all differences reached statistical significance, primarily the cognitive component of the RT is affected in a-MCI. Intra-individual variability and RT of the complex tasks are the best predictors for a-MCI and AD status, respectively. We conclude that performance variability can be regarded as a useful preclinical marker for AD.

Entities:  

Mesh:

Year:  2008        PMID: 18838743     DOI: 10.1177/0891988708320973

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  33 in total

1.  Brief report: the temporal stability of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index in geriatric samples.

Authors:  Kerry M O'Mahar; Kevin Duff; James G Scott; John F Linck; Russell L Adams; James W Mold
Journal:  Arch Clin Neuropsychol       Date:  2011-11-09       Impact factor: 2.813

2.  Level of recall, retrieval speed, and variability on the Cued-Recall Retrieval Speed Task (CRRST) in individuals with amnestic mild cognitive impairment.

Authors:  Wendy S Ramratan; Laura A Rabin; Cuiling Wang; Molly E Zimmerman; Mindy J Katz; Richard B Lipton; Herman Buschke
Journal:  J Int Neuropsychol Soc       Date:  2012-01-23       Impact factor: 2.892

3.  Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.

Authors:  Cindy M de Frias; Roger A Dixon; Richard Camicioli
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

4.  Dealing with short-term fluctuation in longitudinal research.

Authors:  Timothy A Salthouse; John R Nesselroade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-08-23       Impact factor: 4.077

5.  Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil.

Authors:  R H Pietrzak; P Maruff; P J Snyder
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

6.  Are neurocognitive speed and inconsistency similarly affected in type 2 diabetes?

Authors:  Bonnie P Whitehead; Roger A Dixon; David F Hultsch; Stuart W S MacDonald
Journal:  J Clin Exp Neuropsychol       Date:  2011-07       Impact factor: 2.475

7.  Acute Affective Reactivity and Quality of Life in Older Adults with Amnestic Mild Cognitive Impairment: A Functional MRI Study.

Authors:  Ping Ren; Kathi L Heffner; Alanna Jacobs; Feng Lin
Journal:  Am J Geriatr Psychiatry       Date:  2017-06-27       Impact factor: 4.105

8.  RT distributional analysis of cognitive-control-related brain activity in first-episode schizophrenia.

Authors:  Catherine Fassbender; Katie Scangos; Tyler A Lesh; Cameron S Carter
Journal:  Cogn Affect Behav Neurosci       Date:  2014-03       Impact factor: 3.282

Review 9.  Reaction time variability in ADHD: a review.

Authors:  Leanne Tamm; Megan E Narad; Tanya N Antonini; Kathleen M O'Brien; Larry W Hawk; Jeffery N Epstein
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

10.  Reaction time in ankle movements: a diffusion model analysis.

Authors:  Konstantinos P Michmizos; Hermano Igo Krebs
Journal:  Exp Brain Res       Date:  2014-07-17       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.